Trials / Completed
CompletedNCT02240784
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 136 (actual)
- Sponsor
- Alnylam Pharmaceuticals · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2021-04-26
- Completion
- 2021-04-26
- First posted
- 2014-09-16
- Last updated
- 2021-05-17
Locations
30 sites across 20 countries: United States, Australia, Belgium, Bulgaria, Czechia, Finland, France, Germany, Israel, Italy, Mexico, Netherlands, Norway, Poland, South Africa, South Korea, Spain, Switzerland, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT02240784. Inclusion in this directory is not an endorsement.